A REVIEW OF EVEROLIMUS-EXEMESTANE COMBINATION TREATMENT IN METASTATIC BREAST CANCER - A REAL-WORLD CLINICAL EXPERIENCE

被引：0
|
作者：
Agarwal, Anupriya [1 ,2 ]
Beith, Jane M. [1 ,2 ]
McNeil, Catriona [1 ,2 ]
机构：
[1] Chris OBrien Lifehouse, Camperdown, NSW, Australia
[2] Royal Prince Alfred Hosp, Camperdown, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
265
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [31] MANAGEMENT OF METASTATIC BREAST CANCER IN REAL-WORLD CLINICAL PRACTICE: RELEVANCE OF TARGETED THERAPY WITH TREATMENT OUTCOMES
    Cadavid, A.
    Casado, D.
    Ricote, I
    Merino-Montero, S.
    Gonzalez, M.
    VALUE IN HEALTH, 2020, 23 : S520 - S520
  • [32] Exemestane-Everolimus-Induced Angioedema in a Woman With Metastatic Breast Cancer: A Case Report and Review
    Grabie, Yisroel Y.
    Ahmed, Adham
    Acharya, Sudeep
    Flamenbaum, Matthew H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [33] Everolimus for the treatment of thymic epithelial tumors (TETs): A real-world experience
    Arango, J. D. Florez
    Montanez, J. C. Benitez
    Botticella, A.
    Aldea, M.
    Le Pechoux, C.
    Grecea, A. M.
    Levy, A.
    Roux, C.
    Frelaut, M.
    Mussot, S.
    Mercier, O.
    Fadel, E.
    Scoazec, J-Y
    Planchard, D.
    Barlesi, F.
    Besse, B.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1429 - S1429
  • [34] Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
    Sarah S. Mougalian
    Jonathan K. Kish
    Jingchuan Zhang
    Djibril Liassou
    Bruce A. Feinberg
    Advances in Therapy, 2021, 38 : 2226 - 2228
  • [35] Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
    Sarah S. Mougalian
    Jonathan K. Kish
    Jingchuan Zhang
    Djibril Liassou
    Bruce A. Feinberg
    Advances in Therapy, 2021, 38 : 3487 - 3487
  • [36] Real-world treatment in patients with HER2+metastatic breast cancer
    Colomer, R.
    Hall, P.
    Szkultecka-Debek, M.
    Bondi, R. C.
    Flinois, A.
    Auziere, S.
    Le Cleac'h, J. Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 197 - 205
  • [37] Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus
    Filieri, M. E.
    Bettelli, S. R.
    Maiorana, A.
    Caprera, C.
    Manfredini, S.
    Caggia, F.
    Iattoni, E.
    Cascinu, S.
    Omarini, C.
    Piacentini, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] Real-world experience of palbociclib and ribociclib: novel oral therapy in metastatic breast cancer
    Garcia-Trevijano Cabetas, M.
    Lucena Martinez, P.
    Jimenez Nacher, I.
    Diaz Almiron, M.
    Zamora Aunon, P.
    Herrero Ambrosio, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (04) : 893 - 899
  • [39] Evaluation of safety and activity of everolimus plus exemestane in metastatic breast cancer: A single institution experience.
    Ferrarini, Ilaria
    Raoufi, Atefeh
    Bertolini, Ilaria
    Fancelli, Sara
    De Angelis, Carmine
    Diodati, Francesca
    Fontana, Andrea
    Salvadori, Barbara
    Landucci, Elisabetta
    Michelotti, Andrea
    Antonuzzo, Andrea
    Roncella, Silvio
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Real-world experience of palbociclib and ribociclib: novel oral therapy in metastatic breast cancer
    M. García-Trevijano Cabetas
    P. Lucena Martínez
    I. Jiménez Nácher
    M. Díaz Almirón
    P. Zamora Auñón
    A. Herrero Ambrosio
    International Journal of Clinical Pharmacy, 2021, 43 : 893 - 899
12345